This review discussed experimental mouse models used in the pre-clinical study of liver fibrosis regression, a pivotal ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

People with cystic fibrosis (CF) have higher chloride levels ... This is done by applying a colorless chemical called pilocarpine along with a mild electric current, which may cause a slight ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

A new study published in the journal of Arthritis & Rheumatology showed that interstitial lung disease (ILD) can occur in ...

MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases: Danbury, Connecticut Tuesday, November 5, 2024, 16:00 Hrs [IST] MannKind Corporation, a company ...

MannKind (MNKD) announced the successful completion of its first-in-human Phase 1 study of nintedanib DPI, or MNKD-201, for pulmonary fibrotic ...

Met primary objective demonstrating nintedanib DPI was safe and well toleratedParticipants did not experience adverse events typically reported ...

Prolonged exposure to silica dust, a common mineral found in materials like kitchen countertops, can lead to silicosis, a ...